A WHITE PAPER

California Management Review, 2007

The Role of Intellectual Property Rights in Biotechnology Innovation

Given the new institutional context of intellectual property rights, we contribute to the discussion of their role in technology transfer with an exploratory data analysis, drawing some lessons from Brazil. We start with a brief presentation of the major institutional changes from the 1990s, showing that TRIPs had different implications in different national innovation systems. We then present aggregated data from patent applications and from expenditures and receipts for the use of intellectual property in some countries with different innovation systems. We make evident that most new technological knowledge is produced in mature innovation systems. Importantly, these countries pay more than the laggard ones for the use of intellectual property, but they are also better compensated than their less advanced counterparts. Finally, we present the recent Brazilian case on intellectual property, which makes evident that the Brazilian Trademark Institute grants more patents to foreigners than to Brazilians in areas that are considered 'leading to the future' with high knowledge intensity.

The Art & Science of an Innovation Office: A Review of the Literature, 2024

This literature review explores "The Art & Science of an Innovation Office," examining the pivotal role of the Innovation Office (IO) in modern organisations as a critical driver of technological advancement and strategic innovation. The review comprehensively analyses the IO’s functions, including technology intelligence, sourcing, management, and intellectual property (IP) portfolio development. It highlights the IO's role in fostering an innovation culture, facilitating collaboration through open innovation, and ensuring alignment with corporate objectives and compliance with ISO standards. The discussion extends to measuring the IO's impact on business performance, addressing qualitative and quantitative metrics demonstrating its contribution to organisational growth and market leadership. Furthermore, the review identifies the challenges faced by the IO in balancing innovation with compliance while also exploring opportunities for enhancing its effectiveness in promoting sustainability and social innovation. Ultimately, this review underscores the significance of the IO as the starting point for effective technology and innovation management, emphasising its vital contribution to achieving sustained competitive advantage in an increasingly dynamic business environment.

The International Association for Management of Technology (IAMOT) is one of the largest scientific associations dealing with the education, research and application of management of technology. The annual conferences held by IAMOT assemble the most important scientists and experts in the field. The 16th conference held in 2007 included papers by experts from 32 countries. This book compiles the best of those papers presented at the conference. It covers topics and issues related to the knowledge economy, commercialization of knowledge, green technologies, and sustainable development.

Technological Forecasting and Social Change, 2014

2015

Conference agenda 169 4

Intellectual property rights play a central role in biotechnology innovation. Patents, in particular, preoccupy research funding agencies, venture capitalists and governments, despite the fact that the value of patents is disputed and their impact continues to foster controversy. Perhaps more crucially to a fuller understanding of innovation, focus on instruments of intellectual property protection over-illuminates one stage of the flow of knowledge in innovation, leaving up- and down-stream phases in relative obscurity. Knowledge is an intangible asset, and is produced, tracked, managed, and accounted for in innovation systems. Yet what remains unclear, and this is problematic, are the respective roles of knowledge and intellectual property management, their relation, and the potential of a broadened perspective on knowledge flows in innovation. Participants at a Canada-U.K. workshop in Edinburgh examined the relationship between intellectual property rights and knowledge management by framing innovation in terms of knowledge management while attempting to bracket off the effects of patenting – the “Un-IP” approach. Eight critical issues arising at the heart of knowledge management and intellectual property rights were articulated, and general consensus emerged that, conceptually speaking, intellectual property rights needed to be subsumed under knowledge management as a particular class of intangible asset. At the same time, however, practical issues associated with patents continued to dominate the discussion, causing deviation away from the primary theme of the workshop, and highlighting the need to more fully explore eight emerging themes and contextualise the role of intellectual property rights.

Technology Management for the Global Future, 2006. PICMET 2006 (Volume:1 ), 2006

The Intelligent Manufacturing Systems (IMS) initiative is the world’s only international multilateral collaborative R&D program comprising Australia, Canada, the EU and Norway, Japan, Korea, Switzerland and the US. It provides a global framework for industry and academia to co-operate on manufacturing R&D throughout the full innovation cycle and to identify partners world-wide. The program’s scheme for the protection of intellectual property has proven to be beneficial to industrial participants, particularly for small and medium-sized companies, for engaging safely in global collaborations. Surveys among participants in IMS projects show that such international collaboration proves beneficial beyond the mere R&D activity as it includes knowledge exchanges on business and market developments as well as extended business collaborations and better cross-cultural understanding. The European part of the IMS initiative between 1995 and 2005 was managed under the European Commission’s research Framework Programs 4, 5 and 6. Since the beginning of IMS, 37 R&D projects have been launched, most of them with European participation. These projects involve more than one thousand companies and research institutions world-wide and represent an international commitment level of around € 400 million (with € 100 million being European by the European Commission’s research Framework Programs). The paper aims to describe the institutional and managerial mechanisms of this globally unique program and to present a first assessment of its impact in the program’s first phase and to discuss options for improvement, mainly from a European perspective.